Applications of Gene Therapy - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 311

[142] Parker JN, Gillespie GY, Love CE, Randall S, Whitley RJ, Markert JM. Engineered
herpes simplex virus expressing IL-12 in the treatment of experimental murine brain
tumors. Proc Natl Acad Sci USA 2000;97:2208-13.
[143] Qin XQ, Tao N, Dergay A, Moy P, Fawell S, Davis A, et al. Interferon-beta gene ther-
apy inhibits tumor formation and causes regression of established tumors in immune-
deficient mice. Proc Natl Acad Sci USA 1998;95:14411-16.
[144] Okada H, Giezeman-Smits KM, Tahara H, Attanucci J, Fellows WK, Lotze MT, et al.
Effective cytokine gene therapy against an intracranial glioma using a retrovirally trans-
duced IL-4 plus HSVtk tumor vaccine. Gene Ther 1999;6:219-26.
[145] Chiocca EA, Smith KM, McKinney B, Palmer CA, Rosenfeld S, Lillehei K, et al. A
phase I trial of Ad.hIFN-beta gene therapy for glioma. Mol Ther 2008;16:618-26.
[146] Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, et al. Inhibition of vas-
cular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo .
Nature 1993;362:841-4.
[147] Im SA, Manzano CG, Fueyo J, Liu TJ, Ke LD, Kim JS, et al. Transfer of anti-sense
vascular endothelial growth factor inhibits tumor growth in vivo. Cancer Res 1999;59:
895-900.
[148] Nitta T, Sato K. Specific inhibition of c-sis protein synthesis and cell proliferation with
antisense oligodeoxy-nucleotides in human glioma cells. Neurosurgery 1994;34:309-15.
[149] Takamiya Y, Short MP, Ezzeddine ZD, Moolten FL, Breakefield XO, Martuza RL.
Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex
virus type-1 thymidine kinase gene and wild type retro- virus kills other tumor cells.
J Neurosci Res 1992;33:493-503.
[150] Markert JM, Medlock MD, Rabkin SD, Gillespie GY, Todo T, et al. Conditionally repli-
cating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results
of a phase I trial. Gene Ther 2000;7:867-74.
[151] Markert JM, Liechty PG, Wang W, Gaston S, Braz E, Karrasch M, et al. Phase Ib trial
of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recur-
rent GBM. Mol Ther 2009;17:199-207.
[152] Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, et al.
Identification of the cystic fibrosis gene: chromosome walking and jumping. Science
1989;245:1059-65.
[153] Knight RA, Hodson ME. Identification of the cystic fibrosis gene. BMJ 1990;300:345-46.
[154] Ballard ST, Trout L, Bebok Z, Sorscher EJ, Crews A. CFTR involvement in chlo-
ride, bicarbonate, and liquid secretion by airway submucosal glands. Am J Physiol
1999;277:L694-9.
[155] Mueller C, Flotte TR. Gene therapy for cystic fibrosis. Clin Rev Allerg Immunol
2008;35:164-78.
[156] Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in
cystic fibrosis. Cell 1993;73:1251-4.
[157] Koch C, Hoiby N. Diagnosis and treatment of cystic fibrosis. Respiration 2000;67:239-47.
[158] Govan JR, Nelson JW. Microbiology of cystic fibrosis lung infections: themes and
issues. J R Soc Med 1993;86:11-18.
[159] Davies JC, Geddes DM, Alton EW. Gene therapy for cystic fibrosis. J Gene Med
2001;3:409-17.
[160] Drumm ML, Pope HA, Cliff WH, Rommens JM, Marvin SA, Tsui LC, et al. Correction
of the cystic fibrosis defect in vitro by retrovirus mediated gene transfer. Cell 1990;62:
1227-33.